Hyperliquid Strategies Reports $1.9B in HYPE Token Reserves, 29.3 Million Tokens Held

iconChainthink
Share
AI summary iconSummary
Hyperliquid Strategies Inc. (PURR) reported $1.9 billion in HYPE token reserves, with 29.3 million tokens held as of June 30. The Nasdaq-listed company increased its holdings through $647 million in equity financing, raising total assets to $2.06 billion. Shareholders' equity reached $1.873 billion with no liabilities. The Fear & Greed Index remains bullish for altcoins to watch, with HYPE tokens demonstrating strong unrealized gains. Net profit for the year was $305.5 million, driven by $709.9 million in gains, partially offset by a one-time loss of $169.2 million from a merger.

ChainThink reports that on August 27, according to an official announcement, Nasdaq-listed HYPE treasury company Hyperliquid Strategies Inc. (ticker: PURR) released its financial results for the fiscal year ended June 30.

The company raised $647 million through equity financing, increasing the HYPE token reserve from an initial 12.5 million to 29.3 million tokens.

Total assets at the end of the period amounted to $2.06 billion, including $149.9 million in cash and cash equivalents, $1.9041 billion in HYPE tokens, $1.8729 billion in shareholders' equity, and zero liabilities.

The net profit for the fiscal year was $305.5 million, primarily driven by $709.9 million in unrealized gains from the HYPE token, offset by a one-time loss of $169.2 million from token asset disposals at the time of business combination.

Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information. Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.